Cargando…
The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study
BACKGROUND: To evaluate the clinical value of metabolic syndrome based on different definitions [American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI), International Diabetes Federation (IDF) and European Group for the Study of Insulin Resistance (EGIR)] in middle-aged and...
Autores principales: | van Herpt, Thijs T. W., Dehghan, Abbas, van Hoek, Mandy, Ikram, M. Arfan, Hofman, Albert, Sijbrands, Eric J. G., Franco, Oscar H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847340/ https://www.ncbi.nlm.nih.gov/pubmed/27117940 http://dx.doi.org/10.1186/s12933-016-0387-4 |
Ejemplares similares
-
Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
por: Nano, Jana, et al.
Publicado: (2020) -
ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study
por: de Vries, Paul S., et al.
Publicado: (2016) -
Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study
por: Brahimaj, Adela, et al.
Publicado: (2017) -
Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study
por: Ligthart, Symen, et al.
Publicado: (2021) -
Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria
por: van Herpt, Thijs T W, et al.
Publicado: (2020)